Nguyen Binh 4
4 · ENDOCYTE INC · Filed May 21, 2013
Insider Transaction Report
Form 4
ENDOCYTE INCECYT
Nguyen Binh
VP of Clinical Affairs
Transactions
- Exercise/Conversion
Common Stock
2013-05-17$3.55/sh+17,300$61,415→ 17,300 total - Exercise/Conversion
Stock Option (right to buy)
2013-05-17−17,300→ 62,700 totalExercise: $3.55Exp: 2022-02-28→ Common Stock (17,300 underlying) - Sale
Common Stock
2013-05-17$14.42/sh−17,300$249,466→ 0 total
Footnotes (2)
- [F1]Shares subject to the option vest annually over a four (4) year period beginning on March 1, 2013.
- [F2]Represents the sale of 17,300 shares in multiple transactions, ranging in price from $14.41 to $14.4701 per share, resulting in a weighted average sale price per share of $14.42. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range.